Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W4WP
|
||||
| Former ID |
DIB011295
|
||||
| Drug Name |
CVT-10216
|
||||
| Synonyms |
CVT-10083; CVT-10200; CVT-10992; ALDH2 antagonists (alcoholism), CV Therapeutics; ALDH2 antagonists (alcoholism), Gilead Palo Alto; Aldehyde dehydrogenase-2 antagonists (alcoholism), CV Therapeutics
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Alcohol use disorders [ICD9: 303; ICD10:F10.2] | Investigative | [1] | ||
| Company |
Gilead Palo Alto Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C24H19NO7S
|
||||
| Canonical SMILES |
O=S(=O)(Nc1ccc(c2coc3c(c2=O)ccc(c3)OCc2cccc(c2)C(=O)O)c<br />c1)C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Aldehyde dehydrogenase, mitochondrial | Target Info | Antagonist | [1] | |
| KEGG Pathway | Glycolysis / Gluconeogenesis | ||||
| Pentose and glucuronate interconversions | |||||
| Ascorbate and aldarate metabolism | |||||
| Fatty acid degradation | |||||
| Valine, leucine and isoleucine degradation | |||||
| Lysine degradation | |||||
| Arginine and proline metabolism | |||||
| Histidine metabolism | |||||
| Tryptophan metabolism | |||||
| beta-Alanine metabolism | |||||
| Glycerolipid metabolism | |||||
| Pyruvate metabolism | |||||
| Metabolic pathways | |||||
| Biosynthesis of antibiotics | |||||
| PathWhiz Pathway | Beta-Alanine Metabolism | ||||
| Ethanol Degradation | |||||
| Histidine Metabolism | |||||
| Valine, Leucine and Isoleucine Degradation | |||||
| Pyruvate Metabolism | |||||
| Oxidation of Branched Chain Fatty Acids | |||||
| Glycine and Serine Metabolism | |||||
| Tryptophan Metabolism | |||||
| WikiPathways | Tryptophan metabolism | ||||
| Fatty Acid Omega Oxidation | |||||
| Phase 1 - Functionalization of compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2595). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.